BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15662117)

  • 1. Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo.
    DeBernardo RL; Littell RD; Luo H; Duska LR; Oliva E; Kirley SD; Lynch MP; Zukerberg LR; Rueda BR
    Cancer Biol Ther; 2005 Jan; 4(1):103-7. PubMed ID: 15662117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Zukerberg LR; DeBernardo RL; Kirley SD; D'Apuzzo M; Lynch MP; Littell RD; Duska LR; Boring L; Rueda BR
    Cancer Res; 2004 Jan; 64(1):202-8. PubMed ID: 14729625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of cables, a novel gene on chromosome 18q, in ovarian cancer.
    Dong Q; Kirley S; Rueda B; Zhao C; Zukerberg L; Oliva E
    Mod Pathol; 2003 Sep; 16(9):863-8. PubMed ID: 13679449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
    Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
    Deng L; Broaddus RR; McCampbell A; Shipley GL; Loose DS; Stancel GM; Pickar JH; Davies PJ
    Clin Cancer Res; 2005 Dec; 11(23):8258-64. PubMed ID: 16322283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
    Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
    Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
    Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.
    Wang X; Wendel JRH; Emerson RE; Broaddus RR; Creighton CJ; Rusch DB; Buechlein A; DeMayo FJ; Lydon JP; Hawkins SM
    Oncogene; 2020 Oct; 39(40):6286-6299. PubMed ID: 32843721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
    Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
    Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
    Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
    Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas.
    Pradhan M; Abeler VM; Danielsen HE; Tropé CG; Risberg BA
    Mod Pathol; 2006 Sep; 19(9):1227-35. PubMed ID: 16729014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.